The DOI matches its Crossref record; 199 of the 199 references it cites were found in a registry or an index.
Non-invasive delivery strategies for biologics
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
Shapiro, A. M. J., Lakey, J. R. T., Ryan, E. A., Korbutt, G. S., Toth, E., Warnock, G. L., Kneteman, N. M., & Rajotte, R. V. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007273430401 · Cited by 5,237
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
Prausnitz, M. R., & Langer, R. (2008) · Nature Biotechnology · doi:10.1038/nbt.1504 · Cited by 3,517
Peptide therapeutics: current status and future directions
Fosgerau, K., & Hoffmann, T. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2014.10.003 · Cited by 3,030
Protein Therapeutics: A Summary and Pharmacological Classification
Leader, B., Baca, Q. J., & Golan, D. E. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2399 · Cited by 2,161
Hyaluronan: from extracellular glue to pericellular cue
Toole, B. P. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1391 · Cited by 2,125
The skin: an indispensable barrier
Proksch, E., Brandner, J. M., & Jensen, J. (2008) · Experimental Dermatology · doi:10.1111/j.1600-0625.2008.00786.x · Cited by 2,054
Hydrogels: From controlled release to pH-responsive drug delivery
Gupta, P., Vermani, K., & Garg, S. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02255-9 · Cited by 1,825
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Lai, S. K., Wang, Y.-Y., & Hanes, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,815
Microneedles for drug and vaccine delivery
Kim, Y.-C., Park, J.-H., & Prausnitz, M. R. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.04.005 · Cited by 1,760
Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers
Ensign, L. M., Cone, R., & Hanes, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.009 · Cited by 1,623
Holmgren, J., & Czerkinsky, C. (2005) · Nature Medicine · doi:10.1038/nm1213 · Cited by 1,562
Microneedles for transdermal drug delivery
Prausnitz, M. R. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.023 · Cited by 1,521
Lane, M. E. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.040 · Cited by 1,486
Current status and future potential of transdermal drug delivery
Prausnitz, M. R., Mitragotri, S., & Langer, R. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1304 · Cited by 1,462
Self-citationCone, R. A. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.008 · Cited by 1,459
Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs
Neslihan Gursoy, R., & Benita, S. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2004.02.001 · Cited by 1,358
Microfabricated Microneedles: A Novel Approach to Transdermal Drug Delivery
Henry, S., McAllister, D. V., Allen, M. G., & Prausnitz, M. R. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980042+ · Cited by 1,346
Inhaling medicines: delivering drugs to the body through the lungs
Patton, J. S., & Byron, P. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2153 · Cited by 1,331
Anselmo, A. C., & Mitragotri, S. (2016) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10003 · Cited by 1,321
Self-citationLabiris, N. R., & Dolovich, M. B. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01892.x · Cited by 1,245
Large Porous Particles for Pulmonary Drug Delivery
Edwards, D. A., Hanes, J., Caponetti, G., Hrkach, J., Ben-Jebria, A., Eskew, M. L., Mintzes, J., Deaver, D., Lotan, N., & Langer, R. (1997) · Science · doi:10.1126/science.276.5320.1868 · Cited by 1,174
Nasal drug delivery—possibilities, problems and solutions
Illum, L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00363-2 · Cited by 1,102
Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus
Lai, S. K., O'Hanlon, D. E., Harrold, S., Man, S. T., Wang, Y.-Y., Cone, R., & Hanes, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608611104 · Cited by 1,050
In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers
Lehr, C.-M., Bouwstra, J. A., Schacht, E. H., & Junginger, H. E. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90353-4 · Cited by 1,035
Healing sound: the use of ultrasound in drug delivery and other therapeutic applications
Mitragotri, S. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1662 · Cited by 980
Self-citationMonoclonal Antibody Pharmacokinetics and Pharmacodynamics
Wang, W., Wang, E., & Balthasar, J. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.170 · Cited by 978
Thorne, R. G., Pronk, G. J., Padmanabhan, V., & Frey, W. H. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.05.029 · Cited by 958
Pharmacokinetic and biodistribution properties of poly(ethylene glycol)–protein conjugates
Caliceti, P. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00108-x · Cited by 947
Veiseh, O., Doloff, J. C., Ma, M., Vegas, A. J., Tam, H. H., Bader, A. R., Li, J., Langan, E., Wyckoff, J., Loo, W. S., et al. (2015) · Nature Materials · doi:10.1038/nmat4290 · Cited by 897
Nanoparticle-Aptamer Bioconjugates
Farokhzad, O. C., Jon, S., Khademhosseini, A., Tran, T.-N. T., LaVan, D. A., & Langer, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2550 · Cited by 897
Transit of pharmaceutical dosage forms through the small intestine.
Davis, S. S., Hardy, J. G., & Fara, J. W. (1986) · Gut · doi:10.1136/gut.27.8.886 · Cited by 853
Yu, J., Zhang, Y., Ye, Y., DiSanto, R., Sun, W., Ranson, D., Ligler, F. S., Buse, J. B., & Gu, Z. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505405112 · Cited by 848
The extracellular matrix as a scaffold for tissue reconstruction
Badylak, S. F. (2002) · Seminars in Cell & Developmental Biology · doi:10.1016/s1084952102000940 · Cited by 818
Ultrasound-Mediated Transdermal Protein Delivery
Mitragotri, S., Blankschtein, D., & Langer, R. (1995) · Science · doi:10.1126/science.7638603 · Cited by 791
Self-citationA Phase I Trial With Transgenic Bacteria Expressing Interleukin-10 in Crohn’s Disease
Braat, H., Rottiers, P., Hommes, D. W., Huyghebaert, N., Remaut, E., Remon, J., van Deventer, S. J. H., Neirynck, S., Peppelenbosch, M. P., & Steidler, L. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.03.028 · Cited by 786
Antibody-Drug Conjugates in Cancer Therapy
Sievers, E. L., & Senter, P. D. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-050311-201823 · Cited by 770
Constantinides, P. P. (1995) · Pharmaceutical Research · doi:10.1023/a:1016268311867 · Cited by 742
The origins and evolution of “controlled” drug delivery systems
Hoffman, A. S. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.08.012 · Cited by 738
Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies
Keizer, R. J., Huitema, A. D. R., Schellens, J. H. M., & Beijnen, J. H. (2010) · Clinical Pharmacokinetics · doi:10.2165/11531280-000000000-00000 · Cited by 725
Transdermal drug delivery: overcoming the skin’s barrier function
Naik, A., Kalia, Y. N., & Guy, R. H. (2000) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(00)00295-9 · Cited by 720
Williams, A. C., & Barry, B. W. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.032 · Cited by 715
Transdermal Drug Delivery: Penetration Enhancement Techniques
Benson, H. (2005) · Current Drug Delivery · doi:10.2174/1567201052772915 · Cited by 712
Vegas, A. J., Veiseh, O., Gürtler, M., Millman, J. R., Pagliuca, F. W., Bader, A. R., Doloff, J. C., Li, J., Chen, M., Olejnik, K., et al. (2016) · Nature Medicine · doi:10.1038/nm.4030 · Cited by 710
Effect of Microneedle Design on Pain in Human Volunteers
Gill, H. S., Denson, D. D., Burris, B. A., & Prausnitz, M. R. (2008) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e31816778f9 · Cited by 701
Oral drug absorption enhancement by chitosan and its derivatives
Thanou, M., Verhoef, J. C., & Junginger, H. E. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00231-9 · Cited by 689
The magic glue hyaluronan and its eraser hyaluronidase: A biological overview
Girish, K. S., & Kemparaju, K. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.02.037 · Cited by 674
Inhaled nanoparticles—A current review
Yang, W., Peters, J. I., & Williams, R. O. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.02.011 · Cited by 666
The skin barrier in healthy and diseased state
Bouwstra, J. A., & Ponec, M. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.06.021 · Cited by 666
Gut microbiome interactions with drug metabolism, efficacy, and toxicity
Wilson, I. D., & Nicholson, J. K. (2017) · Translational Research · doi:10.1016/j.trsl.2016.08.002 · Cited by 656
Antibody–drug conjugates: targeted drug delivery for cancer
Alley, S. C., Okeley, N. M., & Senter, P. D. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.06.170 · Cited by 656
Wang, Y., Lai, S. K., Suk, J. S., Pace, A., Cone, R., & Hanes, J. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200803526 · Cited by 597
Cell encapsulation: Promise and progress
Orive, G., Hernández, R. M., Gascón, A. R., Calafiore, R., Chang, T. M. S., Vos, P. D., Hortelano, G., Hunkeler, D., Lacík, I., Shapiro, A. M. J., et al. (2003) · Nature Medicine · doi:10.1038/nm0103-104 · Cited by 592
Magainins as paradigm for the mode of action of pore forming polypeptides
Matsuzaki, K. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/s0304-4157(98)00014-8 · Cited by 589
PEGylated antibodies and antibody fragments for improved therapy: a review
Chapman, A. P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00026-1 · Cited by 556
Recent advances in the use of cell-penetrating peptides for medical and biological applications☆
Fonseca, S. B., Pereira, M. P., & Kelley, S. O. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.06.001 · Cited by 553
Vegas, A. J., Veiseh, O., Doloff, J. C., Ma, M., Tam, H. H., Bratlie, K., Li, J., Bader, A. R., Langan, E., Olejnik, K., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3462 · Cited by 551
Challenges for the oral delivery of macromolecules
Goldberg, M., & Gomez-Orellana, I. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1067 · Cited by 544
Mucoadhesive drug delivery system: An overview
Boddupalli, B., Mohammed, Z. K., Nath, R., & Banji, D. (2010) · Journal of Advanced Pharmaceutical Technology & Research · doi:10.4103/0110-5558.76436 · Cited by 537
An overview of clinical and commercial impact of drug delivery systems
Anselmo, A. C., & Mitragotri, S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.053 · Cited by 520
Self-citationIs the oral route possible for peptide and protein drug delivery?
Morishita, M., & Peppas, N. A. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.08.005 · Cited by 515
Oral Delivery of Peptide Drugs: Barriers and Developments
Hamman, J. H., Enslin, G. M., & Kotz??, A. F. (2005) · BioDrugs · doi:10.2165/00063030-200519030-00003 · Cited by 499
Buccal Mucosa as A Route for Systemic Drug Delivery: A Review
Patel, D. A., Patel, M., Patel, K. R., et al. (2012) · International Journal of Drug Development and Research · Cited by 499
Dry Powder Inhaler Formulation
Telko, M. J., & Hickey, A. J. (2005) · Respiratory Care · doi:10.4187/respcare.05501209 · Cited by 498
Polymer Microneedles for Controlled-Release Drug Delivery
Park, J.-H., Allen, M. G., & Prausnitz, M. R. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0028-9 · Cited by 493
Intestinal Permeation Enhancers
Aungst, B. J. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/(sici)1520-6017(200004)89:4<429::aid-jps1>3.0.co;2-j · Cited by 489
Micro-scale devices for transdermal drug delivery
Arora, A., Prausnitz, M. R., & Mitragotri, S. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.08.032 · Cited by 464
Self-citationEngineering bacteria for diagnostic and therapeutic applications
Riglar, D. T., & Silver, P. A. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.172 · Cited by 460
Comparison of the mucoadhesive properties of various polymers
GRABOVAC, V, GUGGI, D., & BERNKOPSCHNURCH, A. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.07.006 · Cited by 449
Yun, Y., Cho, Y. W., & Park, K. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.007 · Cited by 444
Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women
Klatt, N. R., Cheu, R., Birse, K., Zevin, A. S., Perner, M., Noël-Romas, L., Grobler, A., Westmacott, G., Xie, I. Y., Butler, J., et al. (2017) · Science · doi:10.1126/science.aai9383 · Cited by 428
Advances in islet encapsulation technologies
Desai, T., & Shea, L. D. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.232 · Cited by 427
Permeability issues in nasal drug delivery
Arora, P., Sharma, S., & Garg, S. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02452-2 · Cited by 426
First-pass metabolism of cyclosporin by the gut
Kolars, J. C., Watkins, P. B., Merion, R. M., & Awni, W. M. (1991) · The Lancet · doi:10.1016/0140-6736(91)92302-i · Cited by 422
Bannunah, A. M., Vllasaliu, D., Lord, J., & Stolnik, S. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500439c · Cited by 421
Penetration and enzymatic barriers to peptide and protein absorption
Lee, V. H. L., & Yamamoto, A. (1989) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(89)90018-5 · Cited by 413
Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery
Desai, P., Patlolla, R. R., & Singh, M. (2010) · Molecular Membrane Biology · doi:10.3109/09687688.2010.522203 · Cited by 411
Oral delivery of insulin using pH‐responsive complexation gels
Lowman, A. M., Morishita, M., Kajita, M., Nagai, T., & Peppas, N. A. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980337n · Cited by 406
Transepithelial Transport of Fc-Targeted Nanoparticles by the Neonatal Fc Receptor for Oral Delivery
Pridgen, E. M., Alexis, F., Kuo, T. T., Levy-Nissenbaum, E., Karnik, R., Blumberg, R. S., Langer, R., & Farokhzad, O. C. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007049 · Cited by 405
Enhancement of transdermal drug delivery via synergistic action of chemicals
Karande, P., & Mitragotri, S. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2009.08.015 · Cited by 399
Self-citationBorchard, G., Lueβen, H. L., de Boer, A. G., Verhoef, J. C., Lehr, C.-M., & Junginger, H. E. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(95)00146-8 · Cited by 393
Carrier-Mediated Intestinal Transport of Drugs
Tsuji, A., & Tamai, I. (1996) · Pharmaceutical Research · doi:10.1023/a:1016086003070 · Cited by 392
Current status and future prospects of needle-free liquid jet injectors
Mitragotri, S. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2076 · Cited by 381
Self-citationA melanin-mediated cancer immunotherapy patch
Ye, Y., Wang, C., Zhang, X., Hu, Q., Zhang, Y., Liu, Q., Wen, D., Milligan, J., Bellotti, A., Huang, L., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aan5692 · Cited by 381
Ionic liquids for oral insulin delivery
Banerjee, A., Ibsen, K., Brown, T., Chen, R., Agatemor, C., & Mitragotri, S. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1722338115 · Cited by 378
Self-citationSkin permeabilization for transdermal drug delivery: recent advances and future prospects
Schoellhammer, C. M., Blankschtein, D., & Langer, R. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.875528 · Cited by 376
Monoclonal Antibodies: A Review
Singh, S., Kumar, N. K., Dwiwedi, P., Charan, J., Kaur, R., Sidhu, P., & Chugh, V. K. (2018) · Current Clinical Pharmacology · doi:10.2174/1574884712666170809124728 · Cited by 371
Pulmonary Surfactant Protein A Enhances the Host-defense Mechanism of Rat Alveolar Macrophages
van Iwaarden, F., Welmers, B., Verhoef, J., Haagsman, H. P., & van Golde, L. M. G. (1990) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/2.1.91 · Cited by 369
The biopharmaceutical aspects of nasal mucoadhesive drug delivery
Ugwoke, M. I., Verbeke, N., & Kinget, R. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011775145 · Cited by 355
Quantitative analysis of the olfactory pathway for drug delivery to the brain
Thorne, R. G., Emory, C. R., Ala, T. A., & Frey, W. H. (1995) · Brain Research · doi:10.1016/0006-8993(95)00637-6 · Cited by 352
Seminars in cell and developmental biology
Smyth, I. M., & Bertram, J. F. (2019) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2018.11.003 · Cited by 351
Moschos, S. A., Jones, S. W., Perry, M. M., Williams, A. E., Erjefalt, J. S., Turner, J. J., Barnes, P. J., Sproat, B. S., Gait, M. J., & Lindsay, M. A. (2007) · Bioconjugate Chemistry · doi:10.1021/bc070077d · Cited by 350
Carino, G. P., & Mathiowitz, E. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00075-1 · Cited by 347
Maintenance of Normoglycemia in Diabetic Mice by Subcutaneous Xenografts of Encapsulated Islets
Lacy, P. E., Hegre, O. D., Gerasimidi-Vazeou, A., Gentile, F. T., & Dionne, K. E. (1991) · Science · doi:10.1126/science.1763328 · Cited by 345
Recent advances in pulmonary drug delivery using large, porous inhaled particles
Edwards, D. A., Ben-Jebria, A., & Langer, R. (1998) · Journal of Applied Physiology · doi:10.1152/jappl.1998.85.2.379 · Cited by 341
The pulmonary surfactant system: biochemical aspects and functional significance
Van Golde, L. M., Batenburg, J. J., & Robertson, B. (1988) · Physiological Reviews · doi:10.1152/physrev.1988.68.2.374 · Cited by 333
Frost, G. I. (2007) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.4.4.427 · Cited by 323
Yamamoto, A., Taniguchi, T., Rikyuu, K., Tsuji, T., Fujita, T., Murakami, M., & Muranishi, S. (1994) · Pharmaceutical Research · doi:10.1023/a:1018968611962 · Cited by 320
Formulation and Physical Characterization of Large Porous Particles for Inhalation
Vanbever, R., Mintzes, J. D., Wang, J., Nice, J., Chen, D., Batycky, R., Langer, R., & Edwards, D. A. (1999) · Pharmaceutical Research · doi:10.1023/a:1018910200420 · Cited by 314
Choonara, B. F., Choonara, Y. E., Kumar, P., Bijukumar, D., du Toit, L. C., & Pillay, V. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2014.07.006 · Cited by 311
Optimisation of floating matrix tablets and evaluation of their gastric residence time
Baumgartner, S., Kristl, J., Vrečer, F., Vodopivec, P., & Zorko, B. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00378-6 · Cited by 309
Conjugates of stimuli-responsive polymers and proteins
Hoffman, A. S., & Stayton, P. S. (2007) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.05.005 · Cited by 307
Particle engineering techniques for inhaled biopharmaceuticals
Shoyele, S. A., & Cawthorne, S. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.010 · Cited by 301
Aguirre, T. A. S., Teijeiro-Osorio, D., Rosa, M., Coulter, I. S., Alonso, M. J., & Brayden, D. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.004 · Cited by 299
Zhou, Q., Jin, J.-F., Zhu, L.-L., Chen, M., Xu, H.-M., Wang, H.-F., Feng, X.-Q., & Zhu, X.-P. (2015) · Patient Preference and Adherence · doi:10.2147/ppa.s87271 · Cited by 296
Bosquillon, C., Lombry, C., Préat, V., & Vanbever, R. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00362-x · Cited by 296
Swelling-controlled release in hydrogel matrices for oral route
Colombo, P. (1993) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(93)90026-z · Cited by 294
Pharmaceutical Inhalation Aerosol Technology
(2003) · CRC Press eBooks · doi:10.1201/9780203912898 · Cited by 292
Ruge, C. A., Kirch, J., & Lehr, C.-M. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70072-9 · Cited by 280
Dlugi, A. M., Miller, J. D., & Knittle, J. (1990) · Fertility and Sterility · doi:10.1016/s0015-0282(16)53755-8 · Cited by 279
Drug permeation enhancement via buccal route: possibilities and limitations
Şenel, S., & Hıncal, A. A. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00269-3 · Cited by 272
Fasano, A., & Uzzau, S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119271 · Cited by 266
Hollander, P. A., Blonde, L., Rowe, R., Mehta, A. E., Milburn, J. L., Hershon, K. S., Chiasson, J.-L., Levin, S. R., & for the Exubera Phase III Study Group (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2356 · Cited by 264
Buccal mucosa as a route for systemic drug delivery: a review.
Shojaei, A. H. (2000) · PubMed · Cited by 253
Oral cavity as a site for bioadhesive drug delivery
Gandhi, R. B., & Robinson, J. R. (1994) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(94)90026-4 · Cited by 251
Transdermal protein delivery by a coadministered peptide identified via phage display
Chen, Y., Shen, Y., Guo, X., Zhang, C., Yang, W., Ma, M., Liu, S., Zhang, M., & Wen, L.-P. (2006) · Nature Biotechnology · doi:10.1038/nbt1193 · Cited by 249
Transdermal Protein Delivery Using Choline and Geranate (CAGE) Deep Eutectic Solvent
Banerjee, A., Ibsen, K., Iwao, Y., Zakrewsky, M., & Mitragotri, S. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201601411 · Cited by 246
Self-citationPharmacokinetics and toxicology of therapeutic proteins: Advances and challenges
Vugmeyster, Y. (2012) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v3.i4.73 · Cited by 242
Enteric coated HPMC capsules designed to achieve intestinal targeting
Cole, E. T., Scott, R. A., Connor, A. L., Wilding, I. R., Petereit, H.-U., Schminke, C., Beckert, T., & Cadé, D. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00871-7 · Cited by 240
Ye, Y., Yu, J., Wang, C., Nguyen, N., Walker, G. M., Buse, J. B., & Gu, Z. (2016) · Advanced Materials · doi:10.1002/adma.201506025 · Cited by 236
Ionic liquid-assisted transdermal delivery of sparingly soluble drugs
Moniruzzaman, M., Tahara, Y., Tamura, M., Kamiya, N., & Goto, M. (2010) · Chemical Communications · doi:10.1039/b907462g · Cited by 235
Permeation Enhancers for Transdermal Drug Delivery
Sinha, V. R., & Kaur, M. P. (2000) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-100100984 · Cited by 230
Recent advances in controlled pulmonary drug delivery
Liang, Z., Ni, R., Zhou, J., & Mao, S. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2014.09.020 · Cited by 226
Computer Simulation of Plasma Insulin and Glucose Dynamics After Subcutaneous Insulin Injection
Berger, M., & Rodbard, D. (1989) · Diabetes Care · doi:10.2337/diacare.12.10.725 · Cited by 223
Delivery of siRNA and other macromolecules into skin and cells using a peptide enhancer
Hsu, T., & Mitragotri, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016152108 · Cited by 209
Self-citationA practical assessment of transdermal drug delivery by skin electroporation
Prausnitz, M. R. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00063-5 · Cited by 207
Microneedles for Drug Delivery via the Gastrointestinal Tract
Traverso, G., Schoellhammer, C. M., Schroeder, A., Maa, R., Lauwers, G. Y., Polat, B. E., Anderson, D. G., Blankschtein, D., & Langer, R. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24182 · Cited by 202
Buccal penetration enhancers—How do they really work?
Nicolazzo, J. A., Reed, B. L., & Finnin, B. C. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.01.024 · Cited by 202
Structural requirements for intestinal absorption of peptide drugs
Pauletti, G. M., Gangwar, S., Knipp, G. T., Nerurkar, M. M., Okumu, F. W., Tamura, K., Siahaan, T. J., & Borchardt, R. T. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(96)01352-1 · Cited by 198
Reversal of Diabetes in BB Rats by Transplantation of Encapsulated Pancreatic Islets
Fan, M.-Y., Lum, Z.-P., Fu, X.-W., Levesque, L., Tai, I. T., & Sun, A. M. (1990) · Diabetes · doi:10.2337/diab.39.4.519 · Cited by 188
Design of a novel hydrogel-based intelligent system for controlled drug release
He, H., Cao, X., & Lee, L. J. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.12.004 · Cited by 187
Scharp, D. W., Swanson, C. J., Olack, B. J., Latta, P. P., Hegre, O. D., Doherty, E. J., Gentile, F. T., Flavin, K. S., Ansara, M. F., & Lacy, P. E. (1994) · Diabetes · doi:10.2337/diab.43.9.1167 · Cited by 184
Ionic liquids for addressing unmet needs in healthcare
Agatemor, C., Ibsen, K. N., Tanner, E. E. L., & Mitragotri, S. (2018) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10083 · Cited by 180
Self-citationChallenges and Opportunities for the Subcutaneous Delivery of Therapeutic Proteins
Turner, M. R., & Balu-Iyer, S. V. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.01.007 · Cited by 175
Pillai, O. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00094-4 · Cited by 172
The Influence of Intestinal Mucus Components on the Diffusion of Drugs
Larhed, A. W., Artursson, P., & Björk, E. (1998) · Pharmaceutical Research · doi:10.1023/a:1011948703571 · Cited by 165
Long Acting Injections and Implants
Wright, J. C., & Burgess, D. J. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0554-2 · Cited by 164
Morales, J. O., Fathe, K., Brunaugh, A. D., Ferrati, S., Li, S., Montenegro-Nicolini, M., Mousavikhamene, Z., McConville, J. T., Prausnitz, M. R., & Smyth, H. D. C. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0054-z · Cited by 160
(B) Mechanisms of peptide and protein absorption
Nellans, H. N. (1991) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(91)90013-3 · Cited by 157
Muranishi, S. (1990) · PubMed · Cited by 154
Cell‐penetrating Peptides as a Novel Transdermal Drug Delivery System
Nasrollahi, S. A., Taghibiglou, C., Azizi, E., & Farboud, E. S. (2012) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12008 · Cited by 151
Safe and Effective Permeation Enhancers for Oral Drug Delivery
Whitehead, K. A., Karr, N., & Mitragotri, S. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9488-9 · Cited by 146
Self-citationDrug delivery with living cells
Fliervoet, L. A. L., & Mastrobattista, E. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.021 · Cited by 143
Enhancing the Buccal Mucosal Delivery of Peptide and Protein Therapeutics
Caon, T., Jin, L., Simões, C. M. O., Norton, R. S., & Nicolazzo, J. A. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1485-1 · Cited by 133
Single‐ and Multiple‐Dose Pharmacokinetics of Long‐acting Injectable Naltrexone
Dunbar, J., Turncliff, R. Z., Dong, Q., Silverman, B. L., Ehrich, E. W., & Lasseter, K. C. (2006) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00052.x · Cited by 131
Overview and Future Potential of Buccal Mucoadhesive Films as Drug Delivery Systems for Biologics
Montenegro-Nicolini, M., & Morales, J. O. (2016) · AAPS PharmSciTech · doi:10.1208/s12249-016-0525-z · Cited by 131
(2006) · CRC Press eBooks · doi:10.3109/9781420019537 · Cited by 130
Rosenstock, J., Cappelleri, J. C., Bolinder, B., & Gerber, R. A. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1318 · Cited by 130
Oral delivery of macromolecules using intestinal patches: applications for insulin delivery
Whitehead, K. A., Shen, Z., & Mitragotri, S. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.04.013 · Cited by 129
Self-citationModeling absorption kinetics of subcutaneous injected soluble insulin
Mosekilde, E., Jensen, K. S., Binder, C., Pramming, S., & Thorsteinsson, B. (1989) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01059088 · Cited by 129
Zhou, X. H. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90071-x · Cited by 128
The Failure of Exubera: Are We Beating a Dead Horse?
Heinemann, L. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200325 · Cited by 122
History of Aerosol Therapy: Liquid Nebulization to MDIs to DPIs
ANDERSON, P. J. (2005) · Respiratory Care · doi:10.4187/respcare.05501139 · Cited by 120
Gefvert, O., Eriksson, B., Persson, P., Helldin, L., Björner, A., Mannaert, E., Remmerie, B., Eerdekens, M., & Nyberg, S. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004924 · Cited by 119
Topical delivery of siRNA into skin using SPACE-peptide carriers
Chen, M., Zakrewsky, M., Gupta, V., Anselmo, A. C., Slee, D. H., Muraski, J. A., & Mitragotri, S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.01.006 · Cited by 116
Self-citationKagan, L., Turner, M. R., Balu‐Iyer, S. V., & Mager, D. E. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0578-3 · Cited by 106
Two-year results of treatment with depot leuprolide acetate for central precocious puberty
Neely, E. K., Hintz, R. L., Parker, B. R., Bachrach, L. K., Cohen, P., Olney, R. C., & Wilson, D. M. (1992) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)81162-x · Cited by 105
Eiamtrakarn, S., Itoh, Y., Kishimoto, J.-I., Yoshikawa, Y., Shibata, N., Murakami, M., & Takada, K. (2002) · Biomaterials · doi:10.1016/s0142-9612(01)00089-8 · Cited by 103
(B) Mechanisms of peptide and protein absorption
Burton, P. S., Conradi, R. A., & Hilgers, A. R. (1991) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(91)90014-4 · Cited by 102
Buccal delivery of small molecules and biologics: of mucoadhesive polymers, films, and nanoparticles
Morales, J. O., & Brayden, D. J. (2017) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2017.07.011 · Cited by 102
Skyler, J. S., Jovanovič, L., Klioze, S. S., Reis, J., Duggan, W. T., & for the Inhaled Human Insulin Type 1 Diabetes Study Group (2007) · Diabetes Care · doi:10.2337/dc06-1863 · Cited by 101
Intestinal mucoadhesive devices for oral delivery of insulin
Banerjee, A., Lee, J. H., & Mitragotri, S. (2016) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10015 · Cited by 98
Self-citationInhaled Insulin: A Breath of Fresh Air? A Review of Inhaled Insulin
Cavaiola, T. S., & Edelman, S. V. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.06.025 · Cited by 96
Epidermal 'turnover time'—a new examination
Bergstresser, P. R., & Taylor, J. R. (1977) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1977.tb07152.x · Cited by 96
Cui, Y., Cui, P., Chen, B., Li, S., & Guan, H. (2017) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2017.1278768 · Cited by 96
(D) Routes of delivery: Case studies
Smith, P. L., Wall, D. A., Gochoco, C. H., & Wilson, G. (1992) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(92)90005-b · Cited by 94
PROGRESS IN CLINICAL ENCAPSULATED ISLET XENOTRANSPLANTATION
Cooper, D., Matsumoto, S., Abalovich, A., Itoh, T., Mourad, N., Gianello, P., Wolf, E., & Cozzi, E. (2016) · Transplantation · doi:10.1097/tp.0000000000001371 · Cited by 92
Recent Advances in Intestinal Macromolecular Drug Delivery via Receptor-Mediated Transport Pathways
Swaan, P. W. (1998) · Pharmaceutical Research · doi:10.1023/a:1011908128045 · Cited by 91
Immunogenicity of Subcutaneously Administered Therapeutic Proteins—a Mechanistic Perspective
Fathallah, A. M., Bankert, R. B., & Balu‐Iyer, S. V. (2013) · The AAPS Journal · doi:10.1208/s12248-013-9510-6 · Cited by 88
Pulmonary Delivery of Salmon Calcitonin Dry Powders Containing Absorption Enhancers in Rats
Kobayashi, S., Kondo, S., & Juni, K. (1996) · Pharmaceutical Research · doi:10.1023/a:1016081301369 · Cited by 85
Silverman, B. L., Blethen, S. L., Reiter, E. O., Attie, K. M., Neuwirth, R. B., & Ford, K. M. (2002) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2002.15.s2.715 · Cited by 85
Ritschel, W. A. (1996) · Clinical Transplantation · doi:10.1111/j.1399-0012.1996.tb00458.x · Cited by 79
Wasserman, R. L. (2017) · Immunotherapy · doi:10.2217/imt-2017-0092 · Cited by 77
Reformulating cyclosporine A (CsA): More than just a life cycle management strategy
Guada, M., Beloqui, A., Kumar, M. N. V. R., Véronique Préat, A., Dios-Viéitez, M. D. C., & Blanco‐Prieto, M. J. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.056 · Cited by 72
Mechanistic Analysis of Chemical Permeation Enhancers for Oral Drug Delivery
Whitehead, K. A., & Mitragotri, S. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9542-2 · Cited by 70
Self-citationFuture prospect of insulin inhalation for diabetic patients: The case of Afrezza versus Exubera
Al-Tabakha, M. M. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.07.025 · Cited by 69
Nasal Delivery of Antimigraine Drugs: Clinical Rationale and Evidence Base
Rapoport, A. M., & Winner, P. K. (2006) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2006.00603.x · Cited by 66
Oral delivery of peptides: opportunities and issues for translation
Brayden, D. J., & Alonso, M. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.10.005 · Cited by 62
Cell Therapy for Type 1 Diabetes: Current and Future Strategies
Aghazadeh, Y., & Nostro, M. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0863-6 · Cited by 62
Narasimhan, C. N., Mach, H., & Shameem, M. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.68 · Cited by 60
Emerging microtechnologies for the development of oral drug delivery devices
Chirra, H. D., & Desai, T. A. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.08.013 · Cited by 60
Kappy, M. S., STUART, T., PERELMAN, A. H., & Clemons, R. D. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-5-1087 · Cited by 58
Delivery of Exenatide and Insulin Using Mucoadhesive Intestinal Devices
Gupta, V., Hwang, B. H., Doshi, N., Banerjee, A., Anselmo, A. C., & Mitragotri, S. (2016) · Annals of Biomedical Engineering · doi:10.1007/s10439-016-1558-x · Cited by 58
Self-citationMulti‐Reservoir Bioadhesive Microdevices for Independent Rate‐Controlled Delivery of Multiple Drugs
Chirra, H. D., & Desai, T. A. (2012) · Small · doi:10.1002/smll.201201367 · Cited by 54
INSULIN IN ALCOHOLIC SOLUTION BY THE MOUTH
Harrison, G. A. (1923) · BMJ · doi:10.1136/bmj.2.3286.1204 · Cited by 50
De Novo Design of Skin‐Penetrating Peptides for Enhanced Transdermal Delivery of Peptide Drugs
Menegatti, S., Zakrewsky, M., Kumar, S., Oliveira, J. S. D., Muraski, J. A., & Mitragotri, S. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201500634 · Cited by 50
Self-citationJain, S., Kambam, S., Thanki, K., & Jain, A. (2015) · RSC Advances · doi:10.1039/c5ra04762e · Cited by 46
The Role of Corneocytes in Skin Transport Revised—A Combined Computational and Experimental Approach
Hansen, S., Nägel, A., Heisig, M., Wittum, G., Neumann, D., Kostka, K., Meiers, P., Lehr, C., & Schaefer, U. F. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9849-7 · Cited by 39
Kundu, N., Roy, S., Mukherjee, D., Maiti, T. K., & Sarkar, N. (2017) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.7b06231 · Cited by 35
Newby, J., Schiller, J. L., Wessler, T., Edelstein, J., Forest, M. G., & Lai, S. K. (2017) · Nature Communications · doi:10.1038/s41467-017-00739-6 · Cited by 35
Novotný, M., Klimentová, J., Janůšová, B., et al. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.017 · Cited by 30
Inhaled insulin—what went wrong
Mitri, J., & Pittas, A. G. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet1007 · Cited by 28
Inhaled Insulin: Promises and Concerns
Sélam, J.-L. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200225 · Cited by 26
In situ pneumococcal vaccine production and delivery through a hybrid biological-biomaterial vector
Li, Y., Beitelshees, M., Fang, L., Hill, A. B., Ahmadi, M. K., Chen, M., Davidson, B. A., Knight, P. R., Smith, R. J., Andreadis, S. T., et al. (2016) · Science Advances · doi:10.1126/sciadv.1600264 · Cited by 24
Sanofi to propel inhalable insulin Afrezza into market
Kling, J. (2014) · Nature Biotechnology · doi:10.1038/nbt0914-851a · Cited by 15
Forst, T. M., Hohberg, C., Schöndorf, T., Borchert, M., Forst, S., Roth, W., Dehos, B., & Pfützner, A. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0039 · Cited by 13
Rosengren, S., Souratha, J., Conway, D., Muchmore, D. B., & Sugarman, B. J. (2018) · BioDrugs · doi:10.1007/s40259-018-0260-y · Cited by 13
Cited by
The evolution of commercial drug delivery technologies
Vargason, A. M., Anselmo, A. C., & Mitragotri, S. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00698-w · Cited by 1,361
Self-citationAdvances in oral peptide therapeutics
Drucker, D. J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0053-0 · Cited by 646
Makvandi, P., Kirkby, M., Hutton, A. R. J., Shabani, M., Yiu, C. K. Y., Baghbantaraghdari, Z., Jamaledin, R., Carlotti, M., Mazzolai, B., Mattoli, V., et al. (2021) · Nano-Micro Letters · doi:10.1007/s40820-021-00611-9 · Cited by 455
Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers
Haddadzadegan, S., Dorkoosh, F., & Bernkop-Schnürch, A. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114097 · Cited by 424
Hydrogel-Based Controlled Drug Delivery for Cancer Treatment: A Review
Sun, Z., Song, C., Wang, C., Hu, Y., & Wu, J. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b01020 · Cited by 413
Metadata
- Authors
- Anselmo, A. C., Gokarn, Y., & Mitragotri, S.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2018-11-30
- Volume
- 18
- Issue
- 1
- Pages
- 19-40
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2903220880
- Cited by
- 665
- References
- 199
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.